Division of Molecular Oncology & Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Mouse Clinic for Cancer and Aging research (MCCA) Transgenic Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Commun Biol. 2020 May 29;3(1):273. doi: 10.1038/s42003-020-0979-0.
Reporter proteins have become an indispensable tool in biomedical research. However, exogenous introduction of these reporters into mice poses a risk of rejection by the immune system. Here, we describe the generation, validation and application of a multiple reporter protein tolerant 'Tol' mouse model that constitutively expresses an assembly of shuffled reporter proteins from a single open reading frame. We demonstrate that expression of the Tol transgene results in the deletion of CD8 T cells specific for a model epitope, and substantially improves engraftment of reporter-gene transduced T cells. The Tol strain provides a valuable mouse model for cell transfer and viral-mediated gene transfer studies, and serves as a methodological example for the generation of poly-tolerant mouse strains.
报告蛋白已成为生物医学研究中不可或缺的工具。然而,将这些报告蛋白外源导入小鼠会有被免疫系统排斥的风险。在这里,我们描述了一种多报告蛋白耐受“Tol”小鼠模型的产生、验证和应用,该模型从单个开放阅读框组成型表达一个随机化的报告蛋白组装体。我们证明 Tol 转基因的表达导致针对模型表位的 CD8 T 细胞缺失,并显著改善了报告基因转导 T 细胞的植入。Tol 株为细胞转移和病毒介导的基因转移研究提供了一个有价值的小鼠模型,并作为产生多耐受小鼠品系的方法学范例。